The use of radiotracers in drug discovery and development

被引：6
|
作者：
Paans, AMJ [1 ]
机构：
[1] Univ Groningen Hosp, PET Ctr, NL-9700 RB Groningen, Netherlands
来源：
DRUG DISCOVERY TODAY | 2003年 / 8卷 / 16期
关键词：
D O I：
10.1016/S1359-6446(03)02760-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：734 / 734
页数：1
相关论文
共 50 条
  • [21] Biomarker development in drug discovery and development
    Shinagawa, Akira
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 54P - 54P
  • [22] Use of toxicogenomics in drug discovery
    Blomme, E. A. G.
    Yang, Y.
    Waring, J. F.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2006, 161 (03) : 201 - 201
  • [23] Drug metabolism assays and their use in drug discovery
    Bayliss, MK
    Eddershaw, R
    PHARMACOKINETIC CHALLENGES IN DRUG DISCOVERY, 2002, 37 : 69 - 79
  • [24] Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development
    Blomme, Eric A. G.
    Yang, Yi
    Waring, Jeffrey F.
    TOXICOLOGY LETTERS, 2009, 186 (01) : 22 - 31
  • [25] Drug Discovery and Development in Academia
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (06) : 1047 - 1047
  • [26] Antisense drug discovery and development
    Yamamoto, Tsuyoshi
    Nakatani, Moeka
    Narukawa, Keisuke
    Obika, Satoshi
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (03) : 339 - 365
  • [27] Antiviral drug discovery and development
    Nature Reviews Drug Discovery, 2007, 6 : 1019 - 1019
  • [28] ETHNOBOTANICAL DRUG DISCOVERY AND DEVELOPMENT
    TEMPESTA, MS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 100 - AGFD
  • [29] Genetics in drug discovery and development
    Whittaker, John
    JOURNAL OF MEDICAL GENETICS, 2012, 49 : S34 - S34
  • [30] Deuterium in Drug Discovery and Development
    Harbeson, Scott L.
    Tung, Roger D.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 403 - 417
12345